SEC EDGAR CompanyFacts fact · reporting period
CHINA NUOKANG BIO-PHARMACEUTICAL INC.: xbrl:DeferredIncomeTaxExpenseBenefit
One fact, its scope and the complete path back to the official record.
Reported value
$-427.000k{"amount": -427000, "currency": "USD"}- Metric
- xbrl:DeferredIncomeTaxExpenseBenefit
- Period
- 2011-01-01 – 2011-12-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:37:23.909217+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…History
- supersedes {"unit": "CNY", "value": -2689000} (evidence 0001193125-12-232619)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.